Taurine 7 pp 503-511 | Cite as

Inhibition of Taurine Transport by Cyclosporin A is Due to Altered Surface Abundance of the Taurine Transporter and is Reversible

  • Thanh T. Tran
  • Xiaojun Qian
  • Cynthia Edwards
  • Hemanta K. Sarkar
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 643)


We have investigated the underlying mechanism of the CsA-induced {inhibition} of taurine transport using a cell line permanently expressing the mouse taurine transporter (mTauT) tagged with the green-fluorescence protein (GFP). CsA inhibited the uptake activity of the expressed mTauT.GFP fusion protein in both dose and time dependent manner. Surface biotinylation assay revealed that the CsA-treatment reduced the relative surface abundance of the taurine transporter without affecting its total expression level. CsA treatment reduced both the taurine uptake and the relative surface abundance of the transporter by similar magnitudes. Conversely, when the CsA was washed off, both the uptake and the relative surface abundance of the transporter recovered fully to the control level. Remarkably, the recovery process was insensitive to the protein synthesis inhibitor cycloheximide. These results suggested that the CsA inhibited taurine transport by altering the surface abundance, possibly by internalization of the expressed taurine transporters.


Intrauterine Growth Retardation Taurine Transporter Taurine Uptake Protein Synthesis Inhibitor Cycloheximide Total Expression Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aerts L, Van Assche FA (2002) Taurine and taurine-deficiency in perinatal period. J Perinat Med 30:281–286PubMedCrossRefGoogle Scholar
  2. Chesney RW, Holms RA, Christensen M, Burdreau AM, Han X, Sturman JA (1998) The role of taurine in infant nutrition. Adv Exp Med Biol 442:463–476PubMedGoogle Scholar
  3. Ejiri K, Akahori S, Kudo K, Sekiba K, Ubuka T (1987) Effect of guanidinoethyl sulfonate on tissue concentrations and fetal growth in pregnant rats. Biol Neonate 51:234–240PubMedCrossRefGoogle Scholar
  4. Ghisolfi J, Berrebi A, Nguyen VB, Thouvenot JP, Rolland M, Putet G, Dabadie A, Pontonnier G (1989) Placental taurine and low birth weight infants. Biol Neonate 56:181–185PubMedGoogle Scholar
  5. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163PubMedGoogle Scholar
  6. Karl PI, Fisher SE (1990) Taurine transport by microvillous membrane vesicles and the perfused cotyledon of the human placenta. Am J Physiol 285:C443–C451Google Scholar
  7. Kulanthaivel P, Cool DR, Ramamoorthy S, Mahesh VB, Leibach FH, Ganapathy V (1991) Transport of taurine and its regulation by protein kinase C in JAR human placental choriocarcinoma cell line. Biochem J 277:53–58PubMedGoogle Scholar
  8. Miyamoto Y, Balkovetz DF, Leibach FH, Mahesh VB, Ganapathy V (1988) Na+ + Cl- -gradient-driven, high-affinity, uphill transport of taurine in human placental brush-border membrane vesicles. FEBS Lett 231(1):263-7PubMedCrossRefGoogle Scholar
  9. Norberg S, Powell TL, Jansson T (1998) Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters. Pediatr Res 44:233–238PubMedCrossRefGoogle Scholar
  10. Pickrell MD, Sawers R, Michael J (1988) Pregnancy after renal transplantation:severe intrauterine growth retardation during treatment with cyclosporin A. Br Med J (Clin Res) 296:825CrossRefGoogle Scholar
  11. Qian X, Vinnakota S, Edwards E, Sarkar HK (2000) Molecular characterization of taurine transport in bovine aortic endothelial cells. Biochim Biophys Acta 1509:324–334PubMedCrossRefGoogle Scholar
  12. Ramamoorthy S, Leibach FH, Mahesh VB, Ganapathy V (1992) Selective impairment of taurine transport by cyclosporin A in a human placental cell line. Pediatr Res 32:125–127PubMedCrossRefGoogle Scholar
  13. Redmond HP, Stapleton PP, Neary P, Bouchier-Hayes D (1998) Immunonutrition:The role of taurine. Nutrition 14:599–604PubMedCrossRefGoogle Scholar
  14. Roos S, Powell TL, Jansson T (2004) Human placental taurine transporter in uncomplicated and IUGR pregnancies: cellular localization, protein expression, and regulation. Am J Physiol Regul Integr Comp Physiol 287:R886–R893PubMedGoogle Scholar
  15. Tran TT, Dai W, Sarkar HK (2000) Cyclosporin A inhibits creatine uptake by altering the surface expression of the creatine transporter. J Biol Chem 275:35708–35714PubMedCrossRefGoogle Scholar
  16. Vinnakota S, Qian X, Egal H, Sarthy V, Sarkar HK (1997) Molecular characterization and in situ localization of a mouse retinal taurine transporter. J Neurochem 69:2238–2250PubMedCrossRefGoogle Scholar
  17. Willis FR, Findlay CA, Gorrie MJ, Watson MA, Wilkinson AG, Beattie TJ (2000) Children of renal transplant recipient mothers. J Paediatr Child Health 36:230–235PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Thanh T. Tran
    • 1
  • Xiaojun Qian
  • Cynthia Edwards
  • Hemanta K. Sarkar
  1. 1.Department of Molecular Physiology and BiophysicsBaylor College of MedicineHoustonUSA

Personalised recommendations